Mostrar el registro sencillo del ítem

dc.contributor.authorVal-Blasco, Almudena
dc.contributor.authorZaragoza Sánchez, Carlos 
dc.contributor.authorFernández-Velasco, María
dc.date.accessioned2022-09-12T11:56:53Z
dc.date.available2022-09-12T11:56:53Z
dc.date.issued2022
dc.identifier.issn2452-302Xspa
dc.identifier.urihttp://hdl.handle.net/10641/3092
dc.description.abstractHighlights • Administration of BML-111, a stable LXA4 analog, protects against cardiac dysfunction by avoiding Ca2+ mishandling induced by autoimmune myocarditis in a mouse model. • Beneficial effects of the SPMs on intracellular Ca2+ handling are mainly caused by a regulation of SERCA2A by NRF2. • Cardiac tissue obtained from individuals diagnosed with myocarditis, compared with healthy myocardium tissues, displayed depressed mRNA levels of ATP2A2 (SERCA2A) and NF2L2 (NRF2).spa
dc.language.isoengspa
dc.publisherJACC: Basic to Translational Sciencespa
dc.rightsAtribución-NoComercial-SinDerivadas 3.0 España*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/es/*
dc.subjectCalcium handlingspa
dc.subjectMyocarditisspa
dc.subjectPro-resolving mediatorsspa
dc.titleSpecialized Proresolving Mediators Protect Against Experimental Autoimmune Myocarditis by Modulating Ca2+ Handling and NRF2 Activation.spa
dc.typejournal articlespa
dc.type.hasVersionAMspa
dc.rights.accessRightsopen accessspa
dc.description.extent3992 KBspa
dc.identifier.doi10.1016/j.jacbts.2022.01.009spa
dc.relation.publisherversionhttps://www.sciencedirect.com/science/article/pii/S2452302X22000304?via%3Dihubspa


Ficheros en el ítem

FicherosTamañoFormatoVer
3.-Specialized pro-resolving ...3.897MbPDFVer/

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución-NoComercial-SinDerivadas 3.0 España
Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución-NoComercial-SinDerivadas 3.0 España